Whittier Trust’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-881
Closed -$3K 1691
2022
Q3
$3K Hold
881
﹤0.01% 1530
2022
Q2
$4K Buy
+881
New +$5.42K ﹤0.01% 1481

Other funds holding ORGO

Whittier Trust's ORGO Position: Q4 2022 in Review

Whittier Trust sold out of Organogenesis Holdings (ORGO) in Q4 2022, closing a stake of 881 shares — an estimated $3K sold.

Whittier Trust first reported a position in ORGO in Q2 2022 and held it in 2 quarters. The position peaked at $4K in Q2 2022. 150 funds tracked by Wall St. Rank hold ORGO as of Q4 2022.

  • Whittier Trust reported no remaining Organogenesis Holdings position as of Q4 2022 after selling out during the quarter.
  • Whittier Trust sold 881 Organogenesis Holdings shares in Q4 2022, an estimated $3K.
  • Whittier Trust first reported a position in Organogenesis Holdings in Q2 2022 and held it in 2 quarters.
  • Whittier Trust's Organogenesis Holdings position peaked at $4K in Q2 2022.
  • 150 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2022.

Based on Whittier Trust's 13F filing for Q4 2022, filed 25 Jan 2023.